US 10633363
EPAC1 activators as HIV latency reversal agents (LRA)
granted A61PA61P31/18
Quick answer
US patent 10633363 (EPAC1 activators as HIV latency reversal agents (LRA)) held by The Board of Regents of the University of Texas System expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P31/18